ProShare Advisors LLC Has $22.98 Million Stock Holdings in Stryker Corporation $SYK

ProShare Advisors LLC increased its holdings in shares of Stryker Corporation (NYSE:SYK) by 8.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 65,383 shares of the medical technology company’s stock after purchasing an additional 5,047 shares during the period. ProShare Advisors LLC’s holdings in Stryker were worth $22,980,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in SYK. Corient Private Wealth LLC lifted its stake in Stryker by 104.4% in the second quarter. Corient Private Wealth LLC now owns 2,245,841 shares of the medical technology company’s stock valued at $887,525,000 after buying an additional 1,146,998 shares during the period. Alliancebernstein L.P. increased its stake in shares of Stryker by 13.3% in the 3rd quarter. Alliancebernstein L.P. now owns 6,338,050 shares of the medical technology company’s stock valued at $2,342,987,000 after acquiring an additional 741,542 shares in the last quarter. Strive Asset Management LLC acquired a new position in shares of Stryker during the 3rd quarter valued at $227,389,000. Credit Agricole S A acquired a new position in shares of Stryker during the 3rd quarter valued at $194,045,000. Finally, Pictet Asset Management Holding SA boosted its stake in Stryker by 190.3% during the fourth quarter. Pictet Asset Management Holding SA now owns 466,256 shares of the medical technology company’s stock worth $163,878,000 after acquiring an additional 305,640 shares in the last quarter. 77.09% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have weighed in on the stock. William Blair reaffirmed an “outperform” rating on shares of Stryker in a research note on Thursday, March 5th. TD Cowen cut shares of Stryker from a “buy” rating to a “hold” rating and set a $387.00 price objective on the stock. in a research report on Monday, January 26th. UBS Group reduced their target price on Stryker from $400.00 to $380.00 and set a “neutral” rating for the company in a research note on Tuesday, March 17th. Citigroup decreased their target price on Stryker from $420.00 to $385.00 and set a “buy” rating for the company in a research report on Tuesday, April 7th. Finally, Sanford C. Bernstein set a $410.00 price target on Stryker in a report on Friday, May 1st. Sixteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $395.48.

Insider Activity at Stryker

In other news, VP M Kathryn Fink sold 3,500 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $283.45, for a total value of $992,075.00. Following the transaction, the vice president owned 177 shares in the company, valued at $50,170.65. This trade represents a 95.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 4.60% of the stock is currently owned by company insiders.

Stryker Stock Up 1.0%

Stryker stock opened at $320.99 on Thursday. The firm has a market capitalization of $123.06 billion, a price-to-earnings ratio of 37.15, a price-to-earnings-growth ratio of 2.00 and a beta of 0.80. The firm’s fifty day moving average price is $326.71 and its two-hundred day moving average price is $350.36. Stryker Corporation has a 1-year low of $281.00 and a 1-year high of $404.87. The company has a current ratio of 2.11, a quick ratio of 1.25 and a debt-to-equity ratio of 0.62.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing the consensus estimate of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The business had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $6.34 billion. During the same period in the previous year, the firm earned $2.84 earnings per share. The company’s revenue was up 2.6% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, equities research analysts predict that Stryker Corporation will post 14.98 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be paid a $0.88 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. Stryker’s dividend payout ratio is 40.74%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.